TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Karo Pharma Norge AS
Closing information (x1000 SEK)
Closing information | 2019/12 | 2018/12 | 2017/12 |
Turnover | 0 | 0 | 210 |
Financial expenses | 15,356 | 14,632 | 14,508 |
Earnings before taxes | 54,230 | 106,436 | 11,928 |
Total assets | 1,536,571 | 1,523,629 | 1,405,420 |
Current assets | 83,512 | 104,776 | 65,632 |
Current liabilities | 56,634 | 80,994 | 7,266 |
Equity capital | 1,230,863 | 1,150,941 | 1,051,323 |
- share capital | 289,375 | 346,887 | 265,731 |
Employees (average) | 0 | 0 | 0 |
Shareholders | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Solvency | 80.1% | 75.5% | 74.8% |
Turnover per employee | |||
Profit as a percentage of turnover | 5680.0% | ||
Return on assets (ROA) | 4.5% | 7.9% | 1.9% |
Current ratio | 147.5% | 129.4% | 903.3% |
Return on equity (ROE) | 4.4% | 9.2% | 1.1% |
Change turnover | 0 | -215 | -399,910 |
Change turnover % | -100% | ||
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2019/12 | 2018/12 | 2017/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.